Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.890
+0.120 (2.52%)
At close: Mar 6, 2026, 4:00 PM EST
4.970
+0.080 (1.64%)
After-hours: Mar 6, 2026, 7:55 PM EST
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $337.23 million as of March 6, 2026. Its market cap has increased by 862.40% in one year.
Market Cap
337.23M
Enterprise Value
307.49M
1-Year Change
862.40%
Ranking
Category
Stock Price
$4.89
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $337.23M, an increase of 1,486.05%. That is a compound annual growth rate of 67.93%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 332.24M |
| Foghorn Therapeutics | 332.16M |
| Nautilus Biotechnology | 331.60M |
| Cabaletta Bio | 330.19M |
| Puma Biotechnology | 325.61M |
| XOMA Royalty | 314.45M |
| Aldeyra Therapeutics | 312.65M |
| Adlai Nortye | 309.22M |